Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernasconi, P.
Right arrow Articles by Spreafico, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernasconi, P.
Right arrow Articles by Spreafico, R.
Related Collections
Right arrow All Immunology
Right arrow Autoimmune diseases
Right arrow Encephalitis
Right arrow All Epilepsy/Seizures
Right arrow Partial seizures

Neurology 2002;59:1998-2001
© 2002 American Academy of Neurology
Brief Communications

Similar binding to glutamate receptors by Rasmussen and partial epilepsy patients’ sera

P. Bernasconi, PhD, B. Cipelletti, PhD, L. Passerini, PhD, T. Granata, MD, C. Antozzi, MD, R. Mantegazza, MD and R. Spreafico, MD PhD

From the Immunology and Muscular Pathology Unit (Drs. Bernasconi, Passerini, and Mantegazza) and Departments of Experimental Neurophysiology and Epilepsy (Drs. Cipelletti and Spreafico), Child Neurology (Dr. Granata), and Neuromuscular Diseases (Dr. Antozzi), Istituto Nazionale Neurologico "Carlo Besta," Milan, Italy.

Address correspondence and reprint requests to Dr. Roberto Spreafico, Department of Experimental Neurophysiology and Epilepsy, Istituto Nazionale Neurologico "Carlo Besta," Via Celoria 11, 20133 Milan, Italy; e-mail: spreafico{at}istituto-besta.it

Immunoreactivity of sera from patients with Rasmussen encephalitis (RE) and patients with partial epilepsy (PE) was analyzed by immunohistoblot on rat brain sections and the staining pattern compared with that obtained with antibodies to a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and NMDA receptors. Staining for anti-glutamate receptor 3 (GluR3) was found in 82% of patients with RE and 64% of patients with PE. Histoblot analysis showed a positive staining in GluR3- and NMDA-specific regions of rat brain, providing a comprehensive CNS immunolocalization.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.